WO1993010753A1 - Complexes metalliques de protection solaire absorbant les rayons ultraviolets a - Google Patents
Complexes metalliques de protection solaire absorbant les rayons ultraviolets a Download PDFInfo
- Publication number
- WO1993010753A1 WO1993010753A1 PCT/US1992/009693 US9209693W WO9310753A1 WO 1993010753 A1 WO1993010753 A1 WO 1993010753A1 US 9209693 W US9209693 W US 9209693W WO 9310753 A1 WO9310753 A1 WO 9310753A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sunscreen
- complex
- aluminum
- ethylhexyl
- mixtures
- Prior art date
Links
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 117
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 104
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 44
- 239000002184 metal Substances 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 claims abstract description 91
- 230000005855 radiation Effects 0.000 claims abstract description 25
- 150000001768 cations Chemical class 0.000 claims abstract description 19
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 10
- 230000002633 protecting effect Effects 0.000 claims abstract description 5
- -1 carboxylic acid anions Chemical class 0.000 claims description 38
- 229910052782 aluminium Inorganic materials 0.000 claims description 17
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 17
- 239000003446 ligand Substances 0.000 claims description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical compound [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 claims description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 claims description 10
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 150000001450 anions Chemical class 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 229910052719 titanium Inorganic materials 0.000 claims description 6
- 239000010936 titanium Substances 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 229910052787 antimony Inorganic materials 0.000 claims description 5
- 150000001735 carboxylic acids Chemical class 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 claims description 4
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 4
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 150000004696 coordination complex Chemical class 0.000 claims description 4
- 150000002009 diols Chemical class 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 229910052712 strontium Inorganic materials 0.000 claims description 4
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 4
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 3
- 229910052684 Cerium Inorganic materials 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 claims description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052776 Thorium Inorganic materials 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 229910052788 barium Inorganic materials 0.000 claims description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052790 beryllium Inorganic materials 0.000 claims description 3
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 claims description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- 150000004985 diamines Chemical class 0.000 claims description 3
- 239000001177 diphosphate Substances 0.000 claims description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 3
- 235000011180 diphosphates Nutrition 0.000 claims description 3
- 229910052733 gallium Inorganic materials 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims description 3
- 229910052738 indium Inorganic materials 0.000 claims description 3
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims description 3
- 229910052746 lanthanum Inorganic materials 0.000 claims description 3
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052744 lithium Inorganic materials 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 3
- 229910052750 molybdenum Inorganic materials 0.000 claims description 3
- 239000011733 molybdenum Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229910052758 niobium Inorganic materials 0.000 claims description 3
- 239000010955 niobium Substances 0.000 claims description 3
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 claims description 3
- 239000013110 organic ligand Substances 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 229910052715 tantalum Inorganic materials 0.000 claims description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 claims description 2
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 claims description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 2
- 229920000388 Polyphosphate Polymers 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 229960005193 avobenzone Drugs 0.000 claims description 2
- 229910052797 bismuth Inorganic materials 0.000 claims description 2
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 claims description 2
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 claims description 2
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000007764 o/w emulsion Substances 0.000 claims description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 claims description 2
- 229960000601 octocrylene Drugs 0.000 claims description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 239000001205 polyphosphate Substances 0.000 claims description 2
- 235000011176 polyphosphates Nutrition 0.000 claims description 2
- 229920006295 polythiol Polymers 0.000 claims description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000368 sulisobenzone Drugs 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 229910052718 tin Inorganic materials 0.000 claims description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 2
- 229910052721 tungsten Inorganic materials 0.000 claims description 2
- 239000010937 tungsten Substances 0.000 claims description 2
- 229910052726 zirconium Inorganic materials 0.000 claims description 2
- SCMSRHIBVBIECI-UHFFFAOYSA-N [2-hydroxy-4-(2-hydroxyethoxy)phenyl]-phenylmethanone Chemical compound OC1=CC(OCCO)=CC=C1C(=O)C1=CC=CC=C1 SCMSRHIBVBIECI-UHFFFAOYSA-N 0.000 claims 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 2
- LLYCMZGLHLKPPU-UHFFFAOYSA-M perbromate Chemical compound [O-]Br(=O)(=O)=O LLYCMZGLHLKPPU-UHFFFAOYSA-M 0.000 claims 2
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 claims 1
- UONRGKALIXPQDW-UHFFFAOYSA-N C1=CC(N(C)CC(CC)CCCC)=CC=C1C(=O)OCCOC1=CC=C(C(=O)CC(=O)C=2C=CC=CC=2)C=C1 Chemical compound C1=CC(N(C)CC(CC)CCCC)=CC=C1C(=O)OCCOC1=CC=C(C(=O)CC(=O)C=2C=CC=CC=2)C=C1 UONRGKALIXPQDW-UHFFFAOYSA-N 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 claims 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims 1
- 229940114081 cinnamate Drugs 0.000 claims 1
- 150000004662 dithiols Chemical class 0.000 claims 1
- 229960004881 homosalate Drugs 0.000 claims 1
- 229960003921 octisalate Drugs 0.000 claims 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 claims 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims 1
- 229960001173 oxybenzone Drugs 0.000 claims 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 239000007762 w/o emulsion Substances 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 14
- 230000009931 harmful effect Effects 0.000 abstract description 8
- 239000000839 emulsion Substances 0.000 description 25
- 239000004615 ingredient Substances 0.000 description 15
- 239000002904 solvent Substances 0.000 description 14
- 241000894007 species Species 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- 230000000699 topical effect Effects 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 125000002091 cationic group Chemical group 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002562 thickening agent Substances 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 8
- 230000004224 protection Effects 0.000 description 8
- 239000000499 gel Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- KLMDYFUUSKOJAX-UHFFFAOYSA-K aluminum;acetate;dihydroxide Chemical compound CC(=O)O[Al](O)O KLMDYFUUSKOJAX-UHFFFAOYSA-K 0.000 description 5
- 150000003863 ammonium salts Chemical class 0.000 description 5
- 125000000129 anionic group Chemical group 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000003974 emollient agent Substances 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 4
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- HQQUTGFAWJNQIP-UHFFFAOYSA-K aluminum;diacetate;hydroxide Chemical compound CC(=O)O[Al](O)OC(C)=O HQQUTGFAWJNQIP-UHFFFAOYSA-K 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 3
- 150000002085 enols Chemical group 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical class C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- FSEXLNMNADBYJU-UHFFFAOYSA-N 2-phenylquinoline Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=N1 FSEXLNMNADBYJU-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- LCKIEQZJEYYRIY-UHFFFAOYSA-N Titanium ion Chemical compound [Ti+4] LCKIEQZJEYYRIY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 150000001649 bromium compounds Chemical class 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003581 cosmetic carrier Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 150000004072 triols Chemical class 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- INOOPDWDPUATRT-UHFFFAOYSA-N 1,3-diphenyl-2-propan-2-ylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)C)C(=O)C1=CC=CC=C1 INOOPDWDPUATRT-UHFFFAOYSA-N 0.000 description 1
- MGSCLIJJRXIOAX-UHFFFAOYSA-N 1,3-diphenylprop-2-en-1-one;2-phenyl-3h-benzimidazole-5-sulfonic acid Chemical compound C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1.N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 MGSCLIJJRXIOAX-UHFFFAOYSA-N 0.000 description 1
- LGELRVBZINVJHX-UHFFFAOYSA-N 1-(3-bromoindazol-2-yl)ethanone;2-phenyl-1,3-benzoxazole Chemical compound C1=CC=CC2=C(Br)N(C(=O)C)N=C21.C1=CC=CC=C1C1=NC2=CC=CC=C2O1 LGELRVBZINVJHX-UHFFFAOYSA-N 0.000 description 1
- KBKGPMDADJLBEM-UHFFFAOYSA-N 1-(4-pentylphenyl)ethanone Chemical compound CCCCCC1=CC=C(C(C)=O)C=C1 KBKGPMDADJLBEM-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- DRBARRGCABOUIE-UHFFFAOYSA-N 2,3-dihydroxy-3-phenylprop-2-enoic acid Chemical class OC(=O)C(O)=C(O)C1=CC=CC=C1 DRBARRGCABOUIE-UHFFFAOYSA-N 0.000 description 1
- WZPLEIAOQJXZJX-UHFFFAOYSA-N 2,3-dihydroxynaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C(O)=CC2=C1 WZPLEIAOQJXZJX-UHFFFAOYSA-N 0.000 description 1
- ZITBHNVGLSVXEF-UHFFFAOYSA-N 2-[2-(16-methylheptadecoxy)ethoxy]ethanol Chemical compound CC(C)CCCCCCCCCCCCCCCOCCOCCO ZITBHNVGLSVXEF-UHFFFAOYSA-N 0.000 description 1
- ICFRVXBXPFMEST-UHFFFAOYSA-N 2-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(CCCC)C(=O)C1=CC=CC=C1 ICFRVXBXPFMEST-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- JCTNVNANPZAULC-UHFFFAOYSA-N 2-methylbenzo[e][1,3]benzoxazole Chemical compound C1=CC=C2C(N=C(O3)C)=C3C=CC2=C1 JCTNVNANPZAULC-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- ZUACFBHNVKYJFQ-UHFFFAOYSA-N 2-tert-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)C(=O)C1=CC=CC=C1 ZUACFBHNVKYJFQ-UHFFFAOYSA-N 0.000 description 1
- BLNXQXNMBAGIHY-UHFFFAOYSA-N 3-hydroxy-6-phenylbenzene-1,2-disulfonic acid Chemical class OS(=O)(=O)C1=C(S(O)(=O)=O)C(O)=CC=C1C1=CC=CC=C1 BLNXQXNMBAGIHY-UHFFFAOYSA-N 0.000 description 1
- LGLDSEPDYUTBNZ-UHFFFAOYSA-N 3-phenylbuta-1,3-dien-2-ylbenzene Chemical compound C=1C=CC=CC=1C(=C)C(=C)C1=CC=CC=C1 LGLDSEPDYUTBNZ-UHFFFAOYSA-N 0.000 description 1
- OGIKFRSUPOOKLB-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid;2-ethylhexyl 2-(dimethylamino)benzoate Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1.CCCCC(CC)COC(=O)C1=CC=CC=C1N(C)C OGIKFRSUPOOKLB-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- KVOJTUXGYQVLAJ-UHFFFAOYSA-N 6,7-dihydroxy-4-methylcoumarin Chemical compound C1=C(O)C(O)=CC2=C1OC(=O)C=C2C KVOJTUXGYQVLAJ-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical class O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ATEFPOUAMCWAQS-UHFFFAOYSA-N 7,8-dihydroxycoumarin Chemical compound C1=CC(=O)OC2=C(O)C(O)=CC=C21 ATEFPOUAMCWAQS-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 150000004325 8-hydroxyquinolines Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical class C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- POUXVNWAMYUPAI-UHFFFAOYSA-M [NH4+].[OH-].[Na+].OC([O-])=O Chemical compound [NH4+].[OH-].[Na+].OC([O-])=O POUXVNWAMYUPAI-UHFFFAOYSA-M 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- DFQBLTARRFCDAP-UHFFFAOYSA-N acetamide;2-aminoethanol Chemical compound CC(N)=O.NCCO.NCCO DFQBLTARRFCDAP-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- JPUHCPXFQIXLMW-UHFFFAOYSA-N aluminium triethoxide Chemical compound CCO[Al](OCC)OCC JPUHCPXFQIXLMW-UHFFFAOYSA-N 0.000 description 1
- 229940083916 aluminum distearate Drugs 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- RDIVANOKKPKCTO-UHFFFAOYSA-K aluminum;octadecanoate;hydroxide Chemical compound [OH-].[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O RDIVANOKKPKCTO-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- ILERWJCWDWTSQB-UHFFFAOYSA-N benzene-1,4-diol diphenylmethanone Chemical class C1(=CC=CC=C1)C(=O)C1=CC=CC=C1.C1(O)=CC=C(O)C=C1 ILERWJCWDWTSQB-UHFFFAOYSA-N 0.000 description 1
- UYIVSZJVGLGKHE-UHFFFAOYSA-N benzoic acid;2-hydroxyacetic acid Chemical compound OCC(O)=O.OC(=O)C1=CC=CC=C1 UYIVSZJVGLGKHE-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229940047187 benzoresorcinol Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229950011260 betanaphthol Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940075509 carbomer 1342 Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- YBGKGTOOPNQOKH-UHFFFAOYSA-N daphnetin Natural products OC1=CC=CC2=C1OC(=O)C=C2O YBGKGTOOPNQOKH-UHFFFAOYSA-N 0.000 description 1
- HOIXTKAYCMNVMY-PVOAASPHSA-N daphnin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=CC(=O)O2)C2=C1O HOIXTKAYCMNVMY-PVOAASPHSA-N 0.000 description 1
- HOIXTKAYCMNVMY-UHFFFAOYSA-N daphnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=CC(=O)O2)C2=C1O HOIXTKAYCMNVMY-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- WCOATMADISNSBV-UHFFFAOYSA-K diacetyloxyalumanyl acetate Chemical compound [Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WCOATMADISNSBV-UHFFFAOYSA-K 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 229960004960 dioxybenzone Drugs 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- NEMFQSKAPLGFIP-UHFFFAOYSA-N magnesiosodium Chemical compound [Na].[Mg] NEMFQSKAPLGFIP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 229950002083 octabenzone Drugs 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- LLYCMZGLHLKPPU-UHFFFAOYSA-N perbromic acid Chemical class OBr(=O)(=O)=O LLYCMZGLHLKPPU-UHFFFAOYSA-N 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- QVLTXCYWHPZMCA-UHFFFAOYSA-N po4-po4 Chemical compound OP(O)(O)=O.OP(O)(O)=O QVLTXCYWHPZMCA-UHFFFAOYSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 229940066765 systemic antihistamines substituted ethylene diamines Drugs 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/58—Metal complex; Coordination compounds
Definitions
- the present invention relates to sunscreen complexes, and m particularly to sunscreen metal complexes, having enhanced absorption.
- These complexes comprise a dibenzoylmeth UVA-absorbing sunscreen complexed to a cationic species, prefera a metal cation. These complexes are useful for protecting the s from the harmful effects of ultraviolet radiation. This invent also relates to compositions containing these complexes.
- UVB nanometer wavelen ultraviolet radiation range
- UVA ultraviolet radiation range
- Another long term hazard of ultraviolet radiation is premat aging of the skin. This condition is characterized by wrinkling yellowing of the skin, along with other physical changes such cracking, telangiectasis (spider vessels), solar kerato (growths), ecchymoses (subcutaneous hemorrhagic lesions), and l of elasticity (sagging).
- telangiectasis spike vessels
- solar kerato growths
- ecchymoses subcutaneous hemorrhagic lesions
- l of elasticity sagging
- sunscreen agents and physical sunblocks are commercial available to protect the skin from UV radiation.
- Examples of physical sunblocks include titanium dioxide and zinc oxide.
- compositions containing high level of these agents are opaque, generally unattractive i color, and are viewed as unacceptable for usage on more than jus the nose or tops of the ears.
- these agents are ve susceptible to rub-off or wear-off resulting in little or n protection.
- sunscreen agents exert their effects throug chemical means, i.e., they absorb ultraviolet radiation so that i cannot penetrate the skin.
- Sunscreens present the user with severa problems. For example, they must be on the surface of the skin a the time of exposure to be effective. Sunscreens are preventativ so one must anticipate being in the sun. To be most effective sunscreens must be on the skin as a continuous uniform film Delivering such a film to the surface of the skin is very difficult
- Most commercially-avaible sunscreen agents are primarily UV absorbers. The number of UVA absorbers is more limited wit benzophenones and dibenzoylmethanes being the most well-known U.S. Patent No.
- It is a still further object of the present invention provide topical sunscreen compositions containing sunscreen me complexes for providing protection for the skin from the damagi effects of UV radiation.
- (A) S is a sunscreen moiety having the general structure
- A is a substituent selected from H, -OR or -NR2 where each R is independently H, straight or branch chain alkyl having from about 1 to about 20 carbon atom (CH2CH2 ⁇ )q-H, or (CH2CH(CH3)0) q -H, wherein q is an integ from 1 to about 8; and B is a substituent selected from straight or branched chain alkyl having from about 1 about 20 carbon atoms, (CH2CH2 ⁇ )q-H, or (CH2CH(CH3)0)q- wherein q is an integer from 1 to about 8;
- (B) m is an integer selected from 1, 2, 3 or 4;
- (C) M is a metal cation, an ammonium cation, or a substitut ammonium cation
- n is an integer selected from 1, 2, 3, or 4;
- (E) L is a ligand comprising a neutral or negatively charg organic or inorganic moiety
- (F) p is an integer from 0, 1, 2, 3 or 4.
- the present invention further relates to compositions containin these complexes, and to methods for providing enhanced protection t the skin of humans or lower animals from the effects of ultraviole radiation.
- the sunscreen metal complexes useful in the present inventio are those having the general structure: (S) m (N)n (Up.
- (S) m represents a dibenzoylmethane sunscreen moiety, where designates the number of moieties present in the complex.
- (M)n represents a cationic species such as a metal, o alternatively ammonium or substituted ammonium, where n designate the number of species present in the complex.
- (L)p represents a ligand, which is optionally present in th complex, where p designates the number of ligands present in th complex.
- the sunscreen metal complexes of the present inventio preferably absorb light in the visible wavelength range (i.e. abov about 400 nm) only weakly or not at all.
- the complexes ar therefore either only lightly colored (e.g., light yellow or crea colored) or are essentially white. This is desirable for cosmeti reasons.
- the sunscreen metal complexes preferably do not hav a € of greater than about 500 for any wavelength above about 400 nm, and most preferably the € is essentially zero for any wavelengt above about 400 nm.
- the sunscreen moieties which comprise the sunscreen complex of the present invention are those containing the dibenzoylmetha chro ophore. This chromophore is characterized as being effecti for strongly absorbing radiation in the UVA range.
- These dibenzo methane sunscreen moieties which comprise the complexes of t instant invention are fully disclosed in U.S. Patent Nos. 4,489,0 and 4,387,089, which have already been incorporated by referenc supra.
- the numb of sunscreen moieties present is designated by , wherein is integer selected from 1 through 8, more preferably m is an integ selected from 1 through 4, even more preferably m is an integ selected from 1 through 3, and most preferably is 2.
- UVA-absorbing dibenzoylmethane sunscre moieties useful in the sunscreen compounds of the present inventi include those of the following general structure:
- A is a substituent of variable positi on the aromatic ring selected from H, -OR or -NR2 where each R i independently H, straight or branched chain alkyl having from abo 1 to about 20 carbon atoms, (CH2CH2 ⁇ ) q -H, or (CH2CH(CH3)0) q - wherein q is an integer from 1 to about 8; and B is a substituent variable position on the aromatic ring selected from H, straight branched chain alkyl having from about 1 to about 20 carbon atom (CH2CH2 ⁇ )q-H, or (CH2CH(CH3)0)q-H, wherein q is an integer from 1 about 8.
- A is preferably para -OCH3 and is para t-butyl, i.e. 4,4'-methoxy-t-butyldibenzoylmethane (CT adopted name: butyl dibenzoylmethane, which is commercial available under the trademark Parsol- 1789 from Givaudan), alternatively A is H and B is para isopropyl, i.e. 4-isopropy dibenzoylmethane (CTFA adopted name: isopropyl dibenzoylmethan which is commercially abailable under the trademark Eusolex R 80 from Merck).
- CTFA isopropyl dibenzoylmethane
- the dibenzoylmetha chromophore is represented as a 1,3-diketone it should be understo that this representation in no way excludes other tautomeric for of the functional group such as the enol form.
- t 1,3-diketone form it is understood that a appropriate enol tautomers are also contemplated and includ herein.
- These tautomeric enol forms of the dibenzoylmetha chromophore can be represented by the following tautomeri structures.
- the dibenzoylmethan chromophore can lose a hydrogen atom to form the correspondin anionic species. This phenonenon is more likely at higher pH value (i.e. alkaline pH values) and when the dibenzoylmethane chromophor is complexed to a cationic species such as a metal.
- pH value i.e. alkaline pH values
- al appropriate anionic forms are also contemplated and included herein
- molar absorptivity value is quantitative measure of the ability of a molecule to absorb ultr violet light at a specified wavelength.
- the molar absorptivi value is expressed at a particular wavelength of light as the mol absorption coefficient (represented herein by " i " which expressed in units of liter/mole cm), which is calculated by t equation:
- a i - lc wherein "1" is the path length (in centimeters) of the absorbi media through which the light passes; "c” is the concentration the chromophore molecule (in moles per liter); and "A” is t "absorbance".
- the absorbance is calculated from the observ difference in the intensity of the particular wavelength of lig before and after passing through the chromophore-molecule-containi absorbing media. Thus, the absorbance is calculated by t equation:
- Absorption maximum means wavelength of radiation at which the chro ophore-containing molecu has the greatest molar absorptivity value relative to wavelengt immediately above and below the absorption maximum waveleng
- absorption maximum is easily identified as a peak in the graph the spectrum generated by the instrument measuring the absorption.
- Absorption maximum (designated herein as ⁇ max) provided for representative sunscreen compounds of the pres invention in the Examples hereinafter.
- the sunscreen complexes of the present invention compris cationic species, preferably a metal, or alternatively ammonium substituted ammonium, represented by the general structure (M
- metal cations useful in the complexes of the pres invention include alkali metal (e.g., sodium and potassiu alkaline earth metal (e.g., calcium and magnesium), and transit and heavy metals (e.g., aluminum and strontium).
- Preferred for in the complexes of the instant invention are the metals selec from the group consisting of aluminum, zinc, calcium, magnesi copper, iron, barium, strontium, zirconium, titanium, ti beryllium, gallium, indium, lanthanum, manganese, antimony, bismut cerium, thorium, niobium, tantalum, antimony, molybdenum, tungste lithium, sodium, potassium and mixtures thereof.
- These met cations are useful in any of their possible valence states and combinations of these states (i.e. where for example some of t metal cations are in one of the cation's allowable valence state and some of the metal cations are in another of the metal cation allowable valence states, etc.).
- the sunscreen complexes of the instant inventi can also comprise complexes with other cationic species such ammonium, substituted ammonium (e.g., mono-, di-, tri- and tetr alkyl and alkoxy substituted), and cations of diamines (e.g., tetr alkyl and alkoxy substituted ethylene diamines).
- other cationic species such as ammonium, substituted ammonium (e.g., mono-, di-, tri- and tetr alkyl and alkoxy substituted), and cations of diamines (e.g., tetr alkyl and alkoxy substituted ethylene diamines).
- preferr cation species include metals selected from the group consisting aluminum, titanium, copper, iron, and zinc.
- alumin cations having a valence of 3 + are most preferred.
- the numb of M species present in the complex is designated by n, wherein n i an integer selected from 1 through 4, more preferably n is integer selected from 1 through 3, even more preferably n is integer selected from 1 and 2, and most preferably n is 1
- the complexes of the insta invention can exist as a mixture of different species havi different n values.
- the M species ca be derived from any suitable sources.
- the cation can b derived from a wide variety of salts.
- salts included metal oxides, hydroxides, fluorides, chlorides, bromides, iodides carbonates, bicarbonates, phosphates, hydrogen phosphates dihydrogen phosphates, alkoxides (e.g., isopropoxide), sulfates hydrogensulfates, nitrates, sulfites, nitrites, borates, chlorates bromates, perchlorates, perbromates, diphosphates, polyphosphates thiocyanates, carboxylates (preferably, acetates and stearates), an mixtures thereof.
- the ammonium or substituted ammonium specie can be derived from a wide variety of ammonium and substitute ammonium sources such as salts (e.g., chlorides, bromides hydroxides, and the like).
- salts e.g., chlorides, bromides hydroxides, and the like.
- compositions of the instant invention preferred source of the cationic species include aluminum monoacetate, aluminu diacetate, aluminum stearate, and mixtures thereof.
- Expeciall preferred is aluminum monoacetate.
- the sunscreen complexes of the present invention optionall comprise an organic or inorganic ligand represented by the genera structure (L) p .
- Both neutral and anionic ligands are useful in th complexes of the present invention.
- Useful organic ligand include, but are not limited to, those selected from the grou consisting of carboxylic acids, dicarboxylic acids, an polycarboxylic acids and their anions; amines, diamines, an polyamines; alcohols, diols, and polyols and their anions; thiol dithiols, and polythiols and their anions; amino acids and the anions; any other pharmaceutically-acceptable organic ligands, a mixtures thereof.
- Useful inorganic ligands include, but are n limited to, water and hydroxide anion, halide (e.g., fluorid chloride, bromide, and iodide), carbonate, bicarbonate, phosphat hydrogen phosphate, dihydrogen phosphate, sulfate, hydrogen sulfat nitrate, sulfite, nitrite, borate, chlorate, bromate, perchlorat perbro ate, diphosphate, polyphsophate, thiocyanate, any oth pharmaceutically-acceptable inorganic ligands, and mixtures thereo
- pharmaceutically-acceptable organic and inorgani ligands as used herein is meant those organic and inorganic ligand which are acceptable from a toxicity viewpoint.
- ligand selected from water, hydroxide anion, and carboxylic acids havin from about 2 to about 22 carbon atoms and their anions ar preferred.
- Other preferred ligands include ethoxide an isopropoxide.
- Especially preferred among the carboxylic acids an their anions are acetic acid and the acetate anion, octanoic aci and the octanoate anion, and stearic acid and the stearate anion.
- th number of ligands present in the complex is designated by p, wherei p is an integer selected from 0 through 4, more preferably p is a integer selected from 0 through 3, even more preferably p is a integer selected from 0 through 2, even more preferably p is a integer selected from 0 and 1, and most preferably p is 0
- the complexes of the instan invention can exist as a mixture of different species havin different p values.
- sunscreen metal complexes of the presen invention include, for example:
- the sunscreen metal complexes of the present invention can prepared as described in the Examples below. In furth embodiments, these complexes can then be directly formulated into desired carrier. Alternatively, these sunscreen complexes can isolated before being formulated into the desired carrier. In y another alternative, these sunscreen complexes can be prepar directly in the desired carrier.
- the sunscreen metal complex is prepared combining a sunscreen compound and a metal salt in a suitab solvent selected from the group consisting of water, acetone, eth acetate, methyl t-butyl ether, Cj-C ⁇ alcohols, diols, triols, C12- alcohols benzoate, chlorinated solvents (e.g., ethylene chloride dimethyl isosorbide, isodecyl neopentanoate, diisopropyl adipat and mixtures thereof.
- a suitab solvent selected from the group consisting of water, acetone, eth acetate, methyl t-butyl ether, Cj-C ⁇ alcohols, diols, triols, C12- alcohols benzoate, chlorinated solvents (e.g., ethylene chloride dimethyl isosorbide, isodecyl neopentanoate, diisopropyl adipat and mixtures thereof.
- Preferred metal salts include tho selected from the group consisting of salts of aluminum, zin calcium, magnesium, copper, iron, barium, strontium, zirconiu titanium, tin, beryllium, gallium, indium, lanthanum, manganes antimony, bismuth, cerium, thorium, niobium, tantalum, antimon molybdenum, tungsten, lithium, sodium, potassium, and mixtur thereof. More preferred are salts of aluminum, titanium, coppe iron, zinc, and mixtures thereof.
- salts aluminum with those selected from the group consisting of alumin acetate, aluminum diacetate, aluminum stearate, aluminum distearat aluminum octanoate, aluminum ethoxide, aluminum isopropoxide, a mixtures thereof, being more preferred, and aluminum diacetate bei most preferred.
- ammonium and substituted ammoni chlorides, bromides, and hydroxides can be employed.
- at least one equivalent of a base can be added i order to facilitate the dissolution of the sunscreen compoun
- the sunscreen compound and the base are prereacted the solvent system before the metal salt is added.
- Preferred bas include sodium hydroxide, potassium hydroxide, ammonium hydroxid sodium bicarbonate, sodium carbonate, and mixtures thereo
- the solvent system can be heated to its boiling poi if required.
- the sunscreen metal complex is isolated a purified, this is preferably accomplished by filtration a evaporation of the filtrate. Additionally, the complex can further purified by recrystallization from a suitable solvent. T Examples given below provide representative preparations of th sunscreen metal complexes and compositions containing them.
- compositions Containing Sunscreen Metal Complexes One or more of the sunscreen complexes of the present inventio can be incorporated into a variety of carriers, includin pharmaceutical and cosmetic carriers, paints, coatings, polymeri maxtrices, fiber matrices, and the like. Preferably, the complexe are incorporated into pharmaceutical and cosmetic carriers.
- the sunscreen metal complexes of the present inventio typically comprise from about 0.1% to about 30.0% by weight of th sunscreen compositions of the present invention, preferably fro about 1% to about 20%, and most preferably from about 5% to abou 15%.
- the compositions of the instant invention can comprise th following components.
- compositions of the instant invention can comprise a saf and effective amount of a topical pharmaceutically-acceptabl carrier or diluent which can be of a variety of different forms.
- “safe and effective” is meant an amount sufficient to act as suitable vehicle for the sunscreen metal complexes and any othe components, but not so much as to cause any side effects or ski reactions.
- “Pharmaceutically-acceptable” means that the carrier i suitable for topical application to the skin without causing an untoward safety or toxicity concerns. In other words, thes carriers are suitable for use on humans and lower animals.
- Th topical carrier can be in the form of an emulsion including, but no limited to, oil-in-water, water-in-oil, water-in-oil-in-water, an oil-in-water-in-silicone emulsions.
- emulsions can cover a broad range of consistencies including thin lotions (which can also be suitable for spray or aerosol delivery), creamy lotions, ligh creams, heavy creams, and the like.
- suitable topical carrier include anhydrous liquid solvents such as oils and alcohols aqueous-based single phase liquid solvents (e.g. hydro-alcoholi).
- the pharmaceutically-acceptable topical carriers in total typically comprise from about 0.1% to about 99.8% by weight of th sunscreen compositions of the present invention, preferably fro about 80% to about 99%, and most preferably from about 85% to abou 95%.
- a preferred topical carrier of the compositions of the instan invention is an oil-in-water type emulsion.
- the pH of these oil-in water emulsion compositions herein is preferably in the range o from about 3.5 to about 9.
- the mean particle size o the dispersed oil phase materials can be in the range of from abou 5 ⁇ to about 10 microns with greater than about 75% of the particle being less than about 12 microns. Additional Sunscreens -
- sunscreening agents include, but are not limited to, for example: Ethylhexyl-p-methoxycinnamate (available as Parsol MCX from Givauda Corporation), p-Aminobenzoic acid, its salts and its derivative 5 (ethyl, isobutyl, glyceryl esters; p-dimethylamino- benzoic acid 2-ethylhexyl N,N-dimethylaminobenzoate; p-Methoxy- cinnamic Aci Diethanolamine Salt (available as Bernel Hydro from Bernel Chemical Co.); Anthranilates (i.e., o-aminobenzoates; methyl, octyl , amy menth
- sunscreens include the solid physical sunblocks suc as titanium dioxide (icronized titanium dioxide, 0.03 microns 0.035 microns, 0.050 microns, and other suitable sizes), zinc oxide silica, iron oxide and the like. Without being limited by theory it is believed that these inorganic materials provide a sunscreenin benefit through reflecting, scattering, and absorbing harmful UV visible, and infrared radiation.
- Other useful sunscreens are those having both a UVA and a UV absorbing chromophore in the same molecule as disclosed in U.S Patent Nos. 5,041,282, 4,999,186 and 4,937,370, and European Paten Application No. 416,837, which have already been incorporated reference herein.
- these additional sunscreens can comprise from zer to about 20% of the composition, preferably from about 0.5% to abou 10%. Exact amounts will vary depending upon the sunscreen chose and the desired Sun Protection Factor (SPF). SPF is a commonly use measure of photoprotection of a sunscreen against erythema. Se Federal Re g ister. Vol. 43, No. 166, pp. 38206-38269, August 25 1978.
- the compositions ca also contain one or more artificial tanning ingredients such a dihydroxyacetone, tyrosine, amino acids, and amino acid derivatives Typically, artificial tanning ingredients can be incorporated int the compositions of the instant invention at levels from about 0.1 to about 10%, and preferably at levels from about 0.1% to about 5%. Thickeners
- compositions of the instan invention is a thickener.
- thickeners which can b employed include, but are not limited to, xanthan gum, magnesiu aluminum silicate, guar gum, cationic guar gum, Rhamsan Gu (available from Kelco Chemical Co.), kelp, algin and alginate salts starch and starch derivatives, hydroxypropylcellulose hydroxyethylcellulose, carboxymethylcellulose, methylcellulose ethylcellulose, smectite clay thickeners such as hectorite an bentonite, sodium magnesium silicate and mixtures thereof.
- suitable thickeners are disclosed in Lochhead, R.Y.
- compositions of th instant invention comprise from about 0.1% to about 5% thickener preferably from about 0.25% to about 2%, and most preferably fro about 0.5% to about 1%.
- Humectants/Moisturizers include magnesium aluminum silicat and xanthan gum and mixtures thereof.
- compositions of the instant invention can also optional contain one or more humectants/moisturizers.
- a variety humectants/moisturizers can be employed and can be present at level of from about 0.5% to about 30%, more preferably from about to about 8% and most preferably from about 3% to about 5%.
- the materials include urea; guanidine; glycolic acid and glycolate sal (e.g. ammonium and quaternary alkyl ammonium); lactic acid a lactate salts (e.g.
- Preferred humectants/moisturizers for use in the compositio of the present invention are the C3-C6 diols and triols. Especial preferred is the triol, glycerin.
- Emollients The compositions of the present invention can al optionally comprise at least one emollient.
- suitabl emollients include, but are not limited to, volatile a non-volatile silicone oils, highly branched hydrocarbons, an non-polar fatty acid and fatty alcohol esters, and mixtures thereo Emollients useful in the instant invention are further described i U.S. Patent No. 4,919,934, to Deckner et al., issued April 24199 which is incorporated herein by reference in its entirety.
- the emollients can typically comprise in total from about 1% t about 50%, preferably from about 1% to about 25%, and mor preferably from about 1% to about 10% by weight of the composition of the present invention.
- emulsifiers ca include any of a wide variety of nonionic, cationic, anionic, an zwitterionic emulsifiers disclosed in the prior patents and othe references. See McCutcheon's, Detergents and Emulsifiers. Nort American Edition (1986), published by Allured Publishing Corpor ation; U.S. Patent No. 5,011,681, to Ciotti et al, issued April 30 1991; U.S. Patent No. 4,421,769, to Dixon et al., issued Decemb 20, 1983; and U.S. Patent No.
- Suitable emulsifier types include esters of glycerin, esters propylene glycol, fatty acid esters of polyethylene glycol, fat acid esters of polypropylene glycol, esters of sorbitol, esters sorbitan anhydrides, carboxylic acid copolymers, esters and ethe of glucose, ethoxylated ethers, ethoxylated alcohols, alky phosphates, polyoxyethylene fatty ether phosphates, fatty aci amides, acyl lactylates, soaps and mixtures thereof.
- Suitable emulsifiers can include, but are not limited to, poly ethylene glycol 20 sorbitan monolaurate (Polysorbate 20) polyethylene glycol 5 soya sterol, Steareth-20, Ceteareth-20, PPG- methyl glucose ether distearate, Ceteth-10, Polysorbate 80, cety phosphate, potassium cetyl phosphate, diethanola ine cety phosphate, Polysorbate 60, glyceryl stearate, PEG-100 stearate, an mixtures thereof.
- Polysorbate 20 polyethylene glycol 20 sorbitan monolaurate
- Polysorbate 20 polyethylene glycol 5 soya sterol
- Steareth-20 Ceteareth-20
- PPG- methyl glucose ether distearate Ceteth-10
- Polysorbate 80 cety phosphate
- potassium cetyl phosphate diethanola ine cety phosphate
- Polysorbate 60 glyceryl stearate
- the emulsifiers can be used individually or as a mixture of tw or more and comprise from about 0.1% to about 10%, preferably fro about 1% to about 7%, and most preferably from about 1% to about 5 of the compositions of the present invention.
- Vitamins optionally, various vitamins can also be included in th compositions of the present invention. Non-limiting example include Vitamin A, and derivatives thereof, ascorbic acid, Vitami B, biotin, Vitamin D, Vitamin E and derivatives thereof such a tocopheryl acetate, panthothenic acid, and mixtures thereof can als be used.
- compositions of the instan invention is a carboxylic copolymer (acrylic acid copolymer).
- Mos preferred is Carbomer 1342 (available as Carbopol 1342 from B.F Goodrich).
- Carbomer 1342 available as Carbopol 1342 from B.F Goodrich.
- th acrylate/alkyl acrylate crosspolymers such as Acrylates/C10-C Alkyl Acrylate Crosspolymer (available as Pemulen TR-1 and Pemul TR-2 from Goodrich). Reference to Include Pemulens.
- These polymers comprise from about 0.025% to about 0.75 preferably from about 0.05% to about 0.25% and most preferably fr about 0.075% to about 0.175%.
- Other Optional Components are preferably from about 0.025% to about 0.75 preferably from about 0.05% to about 0.25% and most preferably fr about 0.075% to about 0.175%.
- additional ingredients can be incorporated in the emulsion compositions of the present invention.
- additional ingredients include various polyme for aiding the film-forming properties and substantivity of th composition (such as a copolymer of eicosene and vinyl pyrrolidone an example of which is available from GAF Chemical Corporation a Ganex V-220 R ); gums, resins, and thickeners; preservatives fo maintaining the antimicrobial integrity of the compositions antioxidants; chelators and sequestrants; anti-acne agents keratolyic agents;and agents suitable for aesthetic purposes such a fragrances, pigments, and colorings.
- Other useful materials included acidic materials such as salicylic acid, lactic acid, glycolic acid benzoic acid, citric acid and the like. Without being limited b theory, it is believed that these acid materials are useful fo maintaining the pH of the composition and enhancing produc performance.
- the present invention further relates to a method for pro tecting the skin of humans or lower animals from the effects of UV and UVB wavelength radiation, such as sunburn and premature aging o the skin.
- a method for pro tecting the skin of humans or lower animals from the effects of UV and UVB wavelength radiation, such as sunburn and premature aging o the skin comprises topically applying to the huma or lower animal an effective coating of a sunscreen agent o composition of the present invention.
- the term "effective coating”, as used herein, means a film of sunscreen agent sufficient to substantially reduce the amount of UVA and UVB wavelength light which reaches the skin's surface.
- an effective coating of the skin is from about 0.5 mg sunscreen agent or composition o the present invention/cm 2 skin to about 5 mg sunscreen agent or composition of the present invention/cm 2 skin. See Federal Register. Vol. 43, No. 166, pp.
- This crude complex is redissolved in approximately 150 m of methylene chloride with heating and is then vacuum filtered usin a coarse, sintered glass funnel to remove any undissolved materials which are washed with methylene chloride (approximately 2 X 20 mL) (Alternatively, other suitable solvents such as chloroform, ethy acetate or methyl t-butyl ether can be used for this redissolvin step.)
- methylene chloride approximately 2 X 20 mL
- other suitable solvents such as chloroform, ethy acetate or methyl t-butyl ether can be used for this redissolvin step.
- the pooled filtrates are extracted with water (approximatel 2 X 100 mL), dried over sodium sulphate, and evaporated by rotar evaporation to yield the sunscreen aluminum complex as a ligh yellow, glassy solid. This solid is suitable for incoporation int a sunscreen composition.
- alumin monoacetate (basic, stabilized with boric acid: Aldrich Chemic Co., Milwaukee, WI) is added to approximately 300 L of absolu ethanol and heated to boiling for approximately 10 minutes.
- 106.33 grams (0.343 moles) of 4,4'-methox t-butyl-dibenzoylmethane acid ester with 4-hydroxydibenzoylmetha is added to approximately 200 mL of acetone and heated to boilin for approximately 10 minutes.
- this sunscreen alumin complex is prepared starting with 1.0 gram of aluminum dioctanoa
- this sunscreen aluminu complex is prepared using 33.75 grams (0.240 moles) of aluminu monoacetate and 91.24 grams (0.343 moles) of 4-isopropyldibenzoyl methane. A light yellow solid is obtained suitable fo incorporation into a sunscreen composition.
- analogous gel compositions can be prepared usin the other sunscreen metal complexes of the instant invention an with other solvents such as isodecylneopentanote, diisopropy adipate, and dimethylisosorbide.
- An emulsion composition is prepared from the followin ingredients using standard methods.
- This emulsion composition is useful for topical application t the skin to provide protection from the harmful effects o ultraviolet radiation.
- An emulsion composition is prepared from the followin ingredients using standard methods.
- This emulsion composition is useful for topical application to the skin to provide protection from the harmful effects of ultraviolet radiation.
- analogous emulsions are prepared using other isolated sunscreen metal complexes of the instant invention.
- Phase A ingredients are combined and heated with stirring t
- Phase B 80°C to form the oil phase.
- Phase B ingredients ar combined and heated with stirring to 80°C.
- Phase A is added t
- Phase B with homogenization to form the emulsion which is the cooled to room temperature with stirring.
- This emulsion composition is useful for topical application t the skin to provide protection from the harmful effects o ultraviolet radiation.
- analogous emulsions are prepared using othe isolated sunscreen metal complexes of the instant invention.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne des complexes métalliques de protection solaire présentant une capacité d'absorption des rayons ultraviolets A améliorée. Ces complexes comprennent, en tant qu'agent de protection solaire absorbant les rayons ultraviolets A, du dibenzoylméthane complexé avec un cation métal. Ces complexes sont utilisés pour protéger la peau des effets nocifs des rayonnements ultraviolets. Cette invention concerne également des procédés de préparation de ces complexes métalliques de protection solaire et des compositions contenant lesdits complexes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80066591A | 1991-11-27 | 1991-11-27 | |
US800,665 | 1991-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993010753A1 true WO1993010753A1 (fr) | 1993-06-10 |
Family
ID=25179024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/009693 WO1993010753A1 (fr) | 1991-11-27 | 1992-11-12 | Complexes metalliques de protection solaire absorbant les rayons ultraviolets a |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1074909A (fr) |
AU (1) | AU3132193A (fr) |
MX (1) | MX9206875A (fr) |
PT (1) | PT101102A (fr) |
WO (1) | WO1993010753A1 (fr) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005150A1 (fr) * | 1993-08-13 | 1995-02-23 | Unilever Plc | Agents antisolaires |
WO2000023042A1 (fr) * | 1998-10-16 | 2000-04-27 | The Procter & Gamble Company | Compositions de protection uv |
EP1002522A1 (fr) * | 1998-11-19 | 2000-05-24 | Beiersdorf Aktiengesellschaft | Complexes d'aluminium avec des dérivés de dibenzoylméthane et compositions cosmétiques ou dermatologiques les contenant |
FR2799120A1 (fr) * | 1999-10-01 | 2001-04-06 | Oreal | Materiau comprenant un filtre uv-a organique et procede de deplacement de la longueur d'onde d'absorption maximale |
EP2196189A1 (fr) | 2001-12-07 | 2010-06-16 | L'oreal | Compositions cosmétiques antisolaires à base d'un mélange synergique de filtres et utilisations |
WO2012101204A1 (fr) | 2011-01-28 | 2012-08-02 | Momentive Performance Materials Gmbh | Composition cosmétique photoprotectrice contre les uv |
WO2014010100A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Composition cosmétique comprenant des particules composites de protection solaire |
WO2014010099A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Pigment composite et son procédé de préparation |
WO2014010098A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Composition cosmétique comprenant des particules composites |
WO2014009097A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Composition cosmétique contenant des particules composites de protection |
WO2014111566A2 (fr) | 2013-01-21 | 2014-07-24 | L'oreal | Composition cosmétique ou dermatologique comprenant une mérocyanine et un agent anti-uv organique insoluble et/ou un agent anti-uv inorganique insoluble |
WO2015191004A1 (fr) * | 2014-06-09 | 2015-12-17 | Agency For Science, Technology And Research | Complexes métalliques |
WO2016030839A1 (fr) | 2014-08-28 | 2016-03-03 | L'oreal | Composition gel/gel comprenant un filtre uv |
WO2016083404A1 (fr) | 2014-11-24 | 2016-06-02 | L'oreal | Composition cosmetique comprenant un phyllosilicate synthetique et un polyol et/ou un filtre uv |
WO2016198581A1 (fr) | 2015-06-11 | 2016-12-15 | L'oreal | Composition comprenant un agent de blocage d'ultraviolet, un polymère hydrophile réticulé anionique, un tensioactif ayant un hlb inférieur ou égal à 5, et un copolymère de silicone |
WO2019096960A1 (fr) | 2017-11-15 | 2019-05-23 | L'oreal | Compositions comprenant au moins un polymère acrylique et au moins un filtre uv organique insoluble |
FR3083093A1 (fr) | 2018-06-28 | 2020-01-03 | L'oreal | Composition photoprotectrice comprenant des particules de silice colloidale |
FR3090329A1 (fr) | 2018-12-21 | 2020-06-26 | L'oreal | Composition comprenant un filtre UV, un polymère hydrophile réticulé anionique, un tensioactif ayant une HLB inférieure ou égale à 5 et un alcane non volatil |
FR3103705A1 (fr) | 2019-11-29 | 2021-06-04 | L'oreal | Composition comprenant un filtre UV, un polymère séquencé à groupe acide phosphonique et une huile hydrocarbonée |
FR3103704A1 (fr) | 2019-11-29 | 2021-06-04 | L'oreal | Composition comprenant un filtre UV, un polymère éthylénique à groupe acide phosphonique et une huile hydrocarbonée |
US11523976B2 (en) | 2012-07-13 | 2022-12-13 | L'oreal | Composite pigment and method for preparing the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0242611A1 (fr) * | 1986-04-02 | 1987-10-28 | Kao Corporation | Composé absorbant les rayons UV de grande longueur d'onde |
EP0293579A1 (fr) * | 1987-04-13 | 1988-12-07 | L'oreal | Compositions cosmétiques contenant un complexe cuivrique de l'acide 3,5-diisopropyl salicylique pour la protection contre le rayonnement UV et utilisation d'un tel composé en cosmétique |
EP0303995A1 (fr) * | 1987-08-17 | 1989-02-22 | Kao Corporation | Absorbeur de rayons ultraviolets de grandes longueurs d'onde, son procédé de préparation et composition cosmétique le contenant |
-
1992
- 1992-11-12 WO PCT/US1992/009693 patent/WO1993010753A1/fr active Application Filing
- 1992-11-12 AU AU31321/93A patent/AU3132193A/en not_active Abandoned
- 1992-11-27 CN CN 92114828 patent/CN1074909A/zh active Pending
- 1992-11-27 PT PT10110292A patent/PT101102A/pt not_active Application Discontinuation
- 1992-11-27 MX MX9206875A patent/MX9206875A/es unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0242611A1 (fr) * | 1986-04-02 | 1987-10-28 | Kao Corporation | Composé absorbant les rayons UV de grande longueur d'onde |
EP0293579A1 (fr) * | 1987-04-13 | 1988-12-07 | L'oreal | Compositions cosmétiques contenant un complexe cuivrique de l'acide 3,5-diisopropyl salicylique pour la protection contre le rayonnement UV et utilisation d'un tel composé en cosmétique |
EP0303995A1 (fr) * | 1987-08-17 | 1989-02-22 | Kao Corporation | Absorbeur de rayons ultraviolets de grandes longueurs d'onde, son procédé de préparation et composition cosmétique le contenant |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005150A1 (fr) * | 1993-08-13 | 1995-02-23 | Unilever Plc | Agents antisolaires |
US5573755A (en) * | 1993-08-13 | 1996-11-12 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Sunscreen agents |
WO2000023042A1 (fr) * | 1998-10-16 | 2000-04-27 | The Procter & Gamble Company | Compositions de protection uv |
EP1002522A1 (fr) * | 1998-11-19 | 2000-05-24 | Beiersdorf Aktiengesellschaft | Complexes d'aluminium avec des dérivés de dibenzoylméthane et compositions cosmétiques ou dermatologiques les contenant |
FR2799120A1 (fr) * | 1999-10-01 | 2001-04-06 | Oreal | Materiau comprenant un filtre uv-a organique et procede de deplacement de la longueur d'onde d'absorption maximale |
WO2001024768A3 (fr) * | 1999-10-01 | 2002-07-11 | Oreal | Materiau comprenant un filtre uv-a organique et procede de deplacement de la longueur d'onde d'absorption maximale |
EP2196189A1 (fr) | 2001-12-07 | 2010-06-16 | L'oreal | Compositions cosmétiques antisolaires à base d'un mélange synergique de filtres et utilisations |
WO2012101204A1 (fr) | 2011-01-28 | 2012-08-02 | Momentive Performance Materials Gmbh | Composition cosmétique photoprotectrice contre les uv |
WO2014010100A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Composition cosmétique comprenant des particules composites de protection solaire |
WO2014010099A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Pigment composite et son procédé de préparation |
WO2014010098A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Composition cosmétique comprenant des particules composites |
WO2014009097A1 (fr) | 2012-07-13 | 2014-01-16 | L'oreal | Composition cosmétique contenant des particules composites de protection |
US11266584B2 (en) | 2012-07-13 | 2022-03-08 | L'oreal | Cosmetic composition comprising composite sunscreen particles |
US11523976B2 (en) | 2012-07-13 | 2022-12-13 | L'oreal | Composite pigment and method for preparing the same |
WO2014111566A2 (fr) | 2013-01-21 | 2014-07-24 | L'oreal | Composition cosmétique ou dermatologique comprenant une mérocyanine et un agent anti-uv organique insoluble et/ou un agent anti-uv inorganique insoluble |
US10934442B2 (en) | 2014-06-09 | 2021-03-02 | Agency For Science, Technology And Research | Metal complexes |
WO2015191004A1 (fr) * | 2014-06-09 | 2015-12-17 | Agency For Science, Technology And Research | Complexes métalliques |
WO2016030839A1 (fr) | 2014-08-28 | 2016-03-03 | L'oreal | Composition gel/gel comprenant un filtre uv |
WO2016083404A1 (fr) | 2014-11-24 | 2016-06-02 | L'oreal | Composition cosmetique comprenant un phyllosilicate synthetique et un polyol et/ou un filtre uv |
WO2016198581A1 (fr) | 2015-06-11 | 2016-12-15 | L'oreal | Composition comprenant un agent de blocage d'ultraviolet, un polymère hydrophile réticulé anionique, un tensioactif ayant un hlb inférieur ou égal à 5, et un copolymère de silicone |
WO2019096960A1 (fr) | 2017-11-15 | 2019-05-23 | L'oreal | Compositions comprenant au moins un polymère acrylique et au moins un filtre uv organique insoluble |
FR3083093A1 (fr) | 2018-06-28 | 2020-01-03 | L'oreal | Composition photoprotectrice comprenant des particules de silice colloidale |
FR3090329A1 (fr) | 2018-12-21 | 2020-06-26 | L'oreal | Composition comprenant un filtre UV, un polymère hydrophile réticulé anionique, un tensioactif ayant une HLB inférieure ou égale à 5 et un alcane non volatil |
FR3103705A1 (fr) | 2019-11-29 | 2021-06-04 | L'oreal | Composition comprenant un filtre UV, un polymère séquencé à groupe acide phosphonique et une huile hydrocarbonée |
FR3103704A1 (fr) | 2019-11-29 | 2021-06-04 | L'oreal | Composition comprenant un filtre UV, un polymère éthylénique à groupe acide phosphonique et une huile hydrocarbonée |
Also Published As
Publication number | Publication date |
---|---|
PT101102A (pt) | 1994-02-28 |
AU3132193A (en) | 1993-06-28 |
CN1074909A (zh) | 1993-08-04 |
MX9206875A (es) | 1993-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1993010753A1 (fr) | Complexes metalliques de protection solaire absorbant les rayons ultraviolets a | |
US5783174A (en) | Photostable sunscreen compositions | |
WO1993011095A1 (fr) | Complexes metalliques de protection solaire absorbant les rayons ultraviolets a | |
DE69917277T2 (de) | Sonnenschutzmittel | |
AU771713B2 (en) | Photostable UV protection compositions | |
JP2820401B2 (ja) | 新規の不溶性のs−トリアジン誘導体とそれらの調製方法およびそれらを含有する組成物とそれらの使用方法 | |
GB2225013A (en) | Metal salts of benzylidene-camphor-sulphonic acids | |
US5968485A (en) | UV protection compositions | |
CA2089950C (fr) | Agents antisolaires | |
US5573755A (en) | Sunscreen agents | |
EP0823418B1 (fr) | Dérivés d'indanylidène et leur utilisation comme absorbateurs d'UV | |
US5972316A (en) | UV protection compositions | |
AU627279B2 (en) | Sunscreen compositions | |
US5976513A (en) | UV protection compositions | |
WO2019050788A1 (fr) | Agents d'écran solaire inorganiques revêtus d'un adduit d'hydroxy cinnamate et de silanol | |
US6290938B1 (en) | Sunscreen compositions | |
US6224854B1 (en) | UV protection compositions | |
WO1993011135A1 (fr) | Procede de preparation de complexes metalliques de protection solaire absorbant les rayons ultra-violets a | |
JPH06128133A (ja) | 紫外線障害防御外用剤 | |
US5453267A (en) | Sunscreen compositions | |
CN1368044A (zh) | 含有视黄醇和能够掩蔽uva辐射的化合物的组合物、特别是化妆品组合物 | |
WO1995000112A1 (fr) | Compositions photoprotectrices comprenant certains agents de chelation | |
NL7905772A (nl) | Allantoine-urocanzuur-complexen. | |
JP2009102387A (ja) | 皮膚外用剤の紫外線防御効果の持続性を向上させる方法 | |
WO1995004519A1 (fr) | Sels difficilement hydrosolubles d'agents antisolaires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MN MW NO PL RO RU SD |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |